How are patients with diffuse large cell lymphoma monitored?

Updated: Jun 12, 2019
  • Author: Shipra Gandhi, MBBS; Chief Editor: Emmanuel C Besa, MD  more...
  • Print
Answer

Monitor patients very carefully while they are receiving chemotherapy, which is administered every 3 weeks. Order complete blood count (CBC) and chemistries frequently for outpatient monitoring. Immediately see patients if they develop any chemotherapy-related adverse effects.

Red blood cell transfusions or erythropoietin or darbepoetin alfa (Aranesp) injections may be required for patients with persistently low hemoglobin values due to disease or chemotherapy.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!